“In Silico Design, ADMET Prediction and Molecular Docking Studies of Novel Cyanopyridine-Substituted 1,3,5-Triazine Derivatives As Potential Anti-Alzheimer Agents”. MEDICARE CHURNING International Journal of Medical Science, Healthcare & Research Innovations, vol. 1, no. 2, July 2026, pp. 16-39, https://doi.org/10.5281/zenodo.21498307.